Ryan T. Sullivan, Senior VP and General Counsel at Anacor Pharmaceuticals, Inc. (ANAC), sold 10,000 shares at $111.03 ($1.1M) on 2015-12-10, disclosed to the SEC on 2015-12-11.
Scheduled sale ($1.1M) by Senior VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.90 | 1,100 | $120K | 10.8% |
| 2 | $110.25 | 4,900 | $540K | 48.9% |
| 3 | $111.03 | 4,000 | $444K | 40.2% |
| Total | $110.41 avg | 10,000 | $1.1M | 100% |
| Filing → |
| ANAC | SELL | 2016-04-29 | $415K | — | Filing → |
| ANAC | SELL | 2016-01-05 | $164K | — | Filing → |
| ANAC | SELL | 2015-05-01 | $168K | — | Filing → |